Looking forward to moderating the "Regulatory Perspectives on Innovative Healthcare Technologies" panel discussion on Monday, November 21st at 10:15 am.  Panel participants include Dr. Damien Bates, Chief Medical Officer & Head of Research, SanBio, Inc.; Ms. Mya Thomae, Vice President, Regulatory, Clinical and Medical Affairs, Illumina, Inc.; Mr. Yoshiaki Tojo, Chief Executive Director, The Japan External Trade Organization, A Ministry of Economy, Trade and Industry; Mr. Michael Werner, Executive  Director, Alliance for Regenerative Medicine; Partner, Holland & Knight LLP.  

Attending this event in the role as Past-President and had a great time teaching a CE course titled "The Role of Toxicologist Post IND:  What Comes Next."